Waldencast Reports Q2 2024 Financial Results
$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs ...
| Ticker |
Sentiment |
Impact |
|
DRVN
|
Somewhat Bullish
|
1 %
|
|
WALD
|
Neutral
|
14 %
|
